TWST:NASDAQ
Twist Bioscience Corp
$166.99
arrow_upward
+7.35%(+11.43) 1D
$166.60
arrow_downward
-0.23% (-0.39)bedtimeAfter hours
Closed: Sep 18, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TWST...
Open
$158.04
High
$167.05
Low
$156.16
Mkt. cap
11.07B
Avg. vol.
1.68M
Volume
3.07M
52-wk high
$167.05
52-wk low
$23.30
EPS
-$2.22
Beta
2.22
Shares outstanding
65.83M
No. of employees
979
Open
$158.04
High
$167.05
Low
$156.16
Mkt. cap
11.07B
Avg. vol.
1.68M
Volume
3.07M
52-wk high
$167.05
52-wk low
$23.30
EPS
-$2.22
Beta
2.22
Shares outstanding
65.83M
No. of employees
979
News stories
From web sources and news partners
Simply Wall Street
·
5 hours ago
Twist Bioscience (TWST) Stock Could Be 16% Undervalued On DNA Synthesis Market Outlook
Timothy Sykes
·
10 hours ago
TWST Jumps As Twist Bioscience Lands Lilly AI Drug Discovery Deal
Timothy Sykes
·
11 hours ago
TWST Surges As Twist Bioscience Wins Eli Lilly AI Deal
Yahoo Finance
·
1 day ago
Why Twist Bioscience Stock Skyrocketed This Week
Profile
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries. Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes. Wikipedia
About Twist Bioscience Corp